Partner Content Partner Content Citius Oncology Signs Exclusive Commercialization Agreement ... Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Sales & Marketing 5 Things to watch at Fierce Pharma Week 2025: What every pha... Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.
Sales & Marketing Sponsored Vault CRM Campaign Manager: Supporting high growth by synchr... Veeva's Paul Shawah and Essential Pharma's Mike Josey discuss Vault CRM Campaign Manager in this video feature.
Sales & Marketing Executing established pharma brand strategy: Key considerati... As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.